A033270 Stock Overview
Engages in the manufacture and sale of pharmaceutical products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Korea United Pharm Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩18,160.00 |
| 52 Week High | ₩26,000.00 |
| 52 Week Low | ₩17,250.00 |
| Beta | 0 |
| 1 Month Change | 1.40% |
| 3 Month Change | -14.54% |
| 1 Year Change | -26.77% |
| 3 Year Change | -60.31% |
| 5 Year Change | 1.45% |
| Change since IPO | 534.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| A033270 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.7% | -2.3% | 0.3% |
| 1Y | -26.8% | 11.7% | -1.5% |
Return vs Industry: A033270 underperformed the KR Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: A033270 underperformed the KR Market which returned -1.5% over the past year.
Price Volatility
| A033270 volatility | |
|---|---|
| A033270 Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A033270 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A033270's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Duk-Young Kang | www.kup.co.kr |
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries.
Korea United Pharm Inc. Fundamentals Summary
| A033270 fundamental statistics | |
|---|---|
| Market cap | ₩271.13b |
| Earnings (TTM) | ₩20.02b |
| Revenue (TTM) | ₩161.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs A033270 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A033270 income statement (TTM) | |
|---|---|
| Revenue | ₩161.44b |
| Cost of Revenue | ₩76.64b |
| Gross Profit | ₩84.80b |
| Other Expenses | ₩64.78b |
| Earnings | ₩20.02b |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A033270 perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yieldn/a
Payout RatioDoes A033270 pay a reliable dividends?
See A033270 dividend history and benchmarks| Korea United Pharm dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 11 2025 |
| Days until Ex dividend | 25 days |
| Days until Dividend pay date | 80 days |
Does A033270 pay a reliable dividends?
See A033270 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 09:55 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2015/09/30 |
| Annual Earnings | 2014/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Korea United Pharm Inc. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Cape Investment & Securities Co., Ltd. |
| Sang-Hun Lee | iM Securities |
| Seogwon Choi | LS Securities Co., Ltd. |